167 related articles for article (PubMed ID: 35513366)
41. Long Non-Coding RNA MAFG-AS1 as a Potential Biomarker for Hepatocellular Carcinoma: Linkage with Tumor Features, Markers, Liver Functions, and Survival Profile.
Tian Y; Wang J; Tian G; Li B; Chen M; Sun X
Front Surg; 2022; 9():848831. PubMed ID: 36034393
[TBL] [Abstract][Full Text] [Related]
42. Upregulation of LncRNA FAM83H-AS1 in hepatocellular carcinoma promotes cell proliferation, migration and invasion by Wnt/β-catenin pathway.
Ma YK; Shen TH; Yang XY
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7855-7862. PubMed ID: 31599410
[TBL] [Abstract][Full Text] [Related]
43. Up-regulated long non-coding RNA ILF3-AS1 indicates poor prognosis of nasopharyngeal carcinoma and promoted cell metastasis.
Yang X; Lin F; Gao F
Int J Biol Markers; 2020 Dec; 35(4):61-70. PubMed ID: 32962500
[TBL] [Abstract][Full Text] [Related]
44. Novel long non-coding RNA LBX2-AS1 indicates poor prognosis and promotes cell proliferation and metastasis through Notch signaling in non-small cell lung cancer.
Tang LX; Su SF; Wan Q; He P; Xhang Y; Cheng XM
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7419-7429. PubMed ID: 31539129
[TBL] [Abstract][Full Text] [Related]
45. The lncRNA ZEB2-AS1 is upregulated in gastric cancer and affects cell proliferation and invasion via miR-143-5p/HIF-1α axis.
Wu F; Gao H; Liu K; Gao B; Ren H; Li Z; Liu F
Onco Targets Ther; 2019; 12():657-667. PubMed ID: 30705594
[TBL] [Abstract][Full Text] [Related]
46. MAFG-AS1 aggravates the progression of pancreatic cancer by sponging miR-3196 to boost NFIX.
Ye L; Feng W; Weng H; Yuan C; Liu J; Wang Z
Cancer Cell Int; 2020 Dec; 20(1):591. PubMed ID: 33298078
[TBL] [Abstract][Full Text] [Related]
47. LncRNA FEZF1-AS1 enhances epithelial-mesenchymal transition (EMT) through suppressing E-cadherin and regulating WNT pathway in non-small cell lung cancer (NSCLC).
He R; Zhang FH; Shen N
Biomed Pharmacother; 2017 Nov; 95():331-338. PubMed ID: 28858731
[TBL] [Abstract][Full Text] [Related]
48. LncRNA FOXD3-AS1 promotes breast cancer progression by mediating ARF6.
Zhang X; Zhao X; Chang L; Liu F; Li C; Ge P
Breast Cancer; 2022 Sep; 29(5):908-920. PubMed ID: 35678943
[TBL] [Abstract][Full Text] [Related]
49. Long non-coding RNA ZEB2-AS1 promotes the proliferation, metastasis and epithelial mesenchymal transition in triple-negative breast cancer by epigenetically activating ZEB2.
Zhang G; Li H; Sun R; Li P; Yang Z; Liu Y; Wang Z; Yang Y; Yin C
J Cell Mol Med; 2019 May; 23(5):3271-3279. PubMed ID: 30825262
[TBL] [Abstract][Full Text] [Related]
50. A review on the roles and molecular mechanisms of MAFG-AS1 in oncogenesis.
Dabbaghi KG; Mashatan N; Faraz O; Bashkandi AH; Shomoossi N; Tabnak P
Pathol Res Pract; 2023 Mar; 243():154348. PubMed ID: 36736142
[TBL] [Abstract][Full Text] [Related]
51. LncRNA HOXD-AS1 promotes epithelial ovarian cancer cells proliferation and invasion by targeting miR-133a-3p and activating Wnt/β-catenin signaling pathway.
Zhang Y; Dun Y; Zhou S; Huang XH
Biomed Pharmacother; 2017 Dec; 96():1216-1221. PubMed ID: 29239819
[TBL] [Abstract][Full Text] [Related]
52. Up-regulated lncRNA AFAP1-AS1 indicates a poor prognosis and promotes carcinogenesis of breast cancer.
Ma D; Chen C; Wu J; Wang H; Wu D
Breast Cancer; 2019 Jan; 26(1):74-83. PubMed ID: 29974352
[TBL] [Abstract][Full Text] [Related]
53. Long non-coding RNA ZNFX1-AS1 promotes the tumor progression and metastasis of colorectal cancer by acting as a competing endogenous RNA of miR-144 to regulate EZH2 expression.
Shi L; Hong X; Ba L; He X; Xiong Y; Ding Q; Yang S; Peng G
Cell Death Dis; 2019 Feb; 10(3):150. PubMed ID: 30770796
[TBL] [Abstract][Full Text] [Related]
54. LncRNA DLX6-AS1 promoted cancer cell proliferation and invasion by attenuating the endogenous function of miR-181b in pancreatic cancer.
An Y; Chen XM; Yang Y; Mo F; Jiang Y; Sun DL; Cai HH
Cancer Cell Int; 2018; 18():143. PubMed ID: 30250401
[TBL] [Abstract][Full Text] [Related]
55. Long Noncoding RNA RGMB-AS1 Indicates a Poor Prognosis and Modulates Cell Proliferation, Migration and Invasion in Lung Adenocarcinoma.
Li P; Zhang G; Li J; Yang R; Chen S; Wu S; Zhang F; Bai Y; Zhao H; Wang Y; Dun S; Chen X; Sun Q; Zhao G
PLoS One; 2016; 11(3):e0150790. PubMed ID: 26950071
[TBL] [Abstract][Full Text] [Related]
56. Long non-coding RNA heart and neural crest derivatives expressed 2-antisense RNA 1 overexpression inhibits the proliferation of cancer cells by reducing RUNX2 expression in triple-negative breast cancer.
Wei M; Liu L; Wang Z
Oncol Lett; 2019 Dec; 18(6):6775-6780. PubMed ID: 31788122
[TBL] [Abstract][Full Text] [Related]
57. LncRNA ST8SIA6-AS1 promotes proliferation, migration and invasion in breast cancer through the p38 MAPK signalling pathway.
Fang K; Hu C; Zhang X; Hou Y; Gao D; Guo Z; Li L
Carcinogenesis; 2020 Sep; 41(9):1273-1281. PubMed ID: 31784750
[TBL] [Abstract][Full Text] [Related]
58. Non-coding RNA MFI2-AS1 promotes colorectal cancer cell proliferation, migration and invasion through miR-574-5p/MYCBP axis.
Li C; Tan F; Pei Q; Zhou Z; Zhou Y; Zhang L; Wang D; Pei H
Cell Prolif; 2019 Jul; 52(4):e12632. PubMed ID: 31094023
[TBL] [Abstract][Full Text] [Related]
59. Long Non-coding RNA ST8SIA6-AS1 Promotes Lung Adenocarcinoma Progression Through Sponging miR-125a-3p.
Cao Q; Yang W; Ji X; Wang W
Front Genet; 2020; 11():597795. PubMed ID: 33363573
[TBL] [Abstract][Full Text] [Related]
60. Long non-coding RNA PRRT3-AS1 silencing inhibits prostate cancer cell proliferation and promotes apoptosis and autophagy.
Fan L; Li H; Wang W
Exp Physiol; 2020 May; 105(5):793-808. PubMed ID: 32086850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
